Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

PCE-DP brightens skin and promotes hair growth by enhancing cell growth and reducing melanin uptake.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Indometacin was chosen for a gel to help treat mastopathy and prevent breast cancer.

PDGF-BB helps young melanocytes grow but stops mature ones from growing, and it makes melanocytes more specialized.

Certain medications can cause serious side effects, so it's important to report them.

The Breast Utility Instrument was developed to assess quality of life in breast cancer patients.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Melatonin and photobiomodulation are effective for treating Alopecia X in German Spitz dogs.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Certain genes and proteins may help diagnose and treat primary cicatricial alopecia.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

Red laser therapy helped regrow hair in an alopecia areata patient within 21 days.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

BM-PHA is as effective and safe as Restylane Perlane for improving nasolabial folds with minor side effects.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.